Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2006 2
2007 2
2009 1
2010 1
2011 1
2012 2
2013 7
2014 3
2015 5
2016 6
2017 3
2018 6
2019 7
2020 9
2021 8
2022 9
2023 16
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
Electrophysiologic Complications in Cancer Patients.
Lee DH, Chandrashekhar S, Fradley MG. Lee DH, et al. Methodist Debakey Cardiovasc J. 2019 Oct-Dec;15(4):282-288. doi: 10.14797/mdcj-15-4-282. Methodist Debakey Cardiovasc J. 2019. PMID: 31988689 Free PMC article. Review.
Cardiac events after standard of care idecabtagene vicleucel for relapsed and refractory multiple myeloma.
Lee DH, Kumar A, Mohammed T, Peres LC, Alsina M, Bachmeier C, Blue BJ, Brayer J, Chandrasekhar S, Grajales Cruz A, De Avila G, Elmariah H, Faramand R, Freeman C, Jain M, Khadka S, Khimani F, Liu H, Nishihori T, Oswald LB, Castaneda Puglianini OA, Shain KH, Smith E, Baz RC, Locke FL, Oliveira GH, Alomar M, Hansen DK. Lee DH, et al. Blood Adv. 2023 Aug 22;7(16):4247-4257. doi: 10.1182/bloodadvances.2023009766. Blood Adv. 2023. PMID: 37307173 Free PMC article.
Cardiovascular Toxicities of Bruton's Tyrosine Kinase Inhibitors.
Pineda-Gayoso R, Alomar M, Lee DH, Fradley MG. Pineda-Gayoso R, et al. Among authors: lee dh. Curr Treat Options Oncol. 2020 Jun 30;21(8):67. doi: 10.1007/s11864-020-00764-6. Curr Treat Options Oncol. 2020. PMID: 32607825 Review.
Cardiac and inflammatory biomarker differences in adverse cardiac events after chimeric antigen receptor T-Cell therapy: an exploratory study.
Lee DH, Chandrasekhar S, Jain MD, Mhaskar R, Reid K, Lee SB, Corallo S, Hidalgo-Vargas MJ, Kumar A, Chavez J, Shah B, Lazaryan A, Khimani F, Nishihori T, Bachmeier C, Faramand R, Fradley MG, Jeong D, Oliveira GH, Locke FL, Davila ML, Alomar M. Lee DH, et al. Cardiooncology. 2023 Apr 1;9(1):18. doi: 10.1186/s40959-023-00170-5. Cardiooncology. 2023. PMID: 37005652 Free PMC article.
Association between ibrutinib treatment and hypertension.
Lee DH, Hawk F, Seok K, Gliksman M, Emole J, Rhea IB, Viganego F, Welter-Frost A, Armanious M, Shah B, Chavez JC, Pinilla-Ibarz J, Schabath MB, Fradley M. Lee DH, et al. Heart. 2022 Mar;108(6):445-450. doi: 10.1136/heartjnl-2021-319110. Epub 2021 Jul 1. Heart. 2022. PMID: 34210750 Free PMC article.
A microscopic view on the renal endothelial glycocalyx.
Dane MJ, van den Berg BM, Lee DH, Boels MG, Tiemeier GL, Avramut MC, van Zonneveld AJ, van der Vlag J, Vink H, Rabelink TJ. Dane MJ, et al. Among authors: lee dh. Am J Physiol Renal Physiol. 2015 May 1;308(9):F956-66. doi: 10.1152/ajprenal.00532.2014. Epub 2015 Feb 11. Am J Physiol Renal Physiol. 2015. PMID: 25673809 Free article. Review.
Electrocardiographic Changes Associated With Ibrutinib Exposure.
Fradley MG, Welter-Frost A, Gliksman M, Emole J, Viganego F, Lee DH, Shah B, Chavez JC, Pinilla-Ibarz J, Schabath MB. Fradley MG, et al. Among authors: lee dh. Cancer Control. 2020 Jan-Dec;27(1):1073274820931808. doi: 10.1177/1073274820931808. Cancer Control. 2020. PMID: 32496158 Free PMC article.
83 results